Sanofi
SNY
$48.66
$0.310.64%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 28.48% | 12.70% | 79.07% | 2.64% | |
| Total Other Revenue | 25.90% | 7.15% | -34.18% | 12.84% | |
| Total Revenue | 28.28% | 12.30% | 58.53% | 3.23% | |
| Cost of Revenue | 21.44% | 6.42% | 39.38% | -3.67% | |
| Gross Profit | 31.42% | 14.75% | 69.18% | 6.22% | |
| SG&A Expenses | 22.79% | 10.60% | 114.63% | -12.58% | |
| Depreciation & Amortization | 43.55% | -2.75% | 36.71% | -27.93% | |
| Other Operating Expenses | 99.96% | 38.78% | -56.57% | 79.04% | |
| Total Operating Expenses | 28.05% | 13.87% | 29.05% | -0.11% | |
| Operating Income | 29.70% | 5.69% | 504.89% | 12.07% | |
| Income Before Tax | -295.79% | 15.64% | 150.94% | 13.61% | |
| Income Tax Expenses | -452.92% | -11.52% | 136.74% | 22.71% | |
| Earnings from Continuing Operations | -264.26% | 22.65% | 155.23% | 11.59% | |
| Earnings from Discontinued Operations | 107.65% | 6,439.06% | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 27.60% | -8.47% | -404.88% | -125.32% | |
| Net Income | -356.99% | 276.56% | 154.31% | 12.61% | |
| EBIT | 29.70% | 5.69% | 504.89% | 12.07% | |
| EBITDA | 30.47% | 1.48% | 852.14% | 9.69% | |
| EPS Basic | -367.82% | 286.74% | 153.50% | 12.63% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -369.88% | 289.65% | 153.09% | 12.63% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -3.09% | -2.59% | -0.02% | -0.02% | |
| Average Diluted Shares Outstanding | -3.46% | -2.93% | -0.02% | -0.02% | |
| Dividend Per Share | 14.78% | -- | 3.23% | -- | |
| Payout Ratio | -8.04% | -- | 0.03% | -- | |